⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL438894 | 0.91 | — | — | |
| SCHEMBL11213990 | 0.88 | EPHX1 (0.50) | — | |
| SCHEMBL22564692 | 0.88 | EPHX1 (0.50) | — | |
| SCHEMBL15346172 | 0.88 | EPHX1 (0.50) | — | |
| SCHEMBL17104335 | 0.88 | EPHX1 (0.50) | — | |
| SCHEMBL25122641 | 0.88 | EPHX1 (0.50) | — | |
| SCHEMBL17104337 | 0.88 | EPHX1 (0.50) | — | |
| SCHEMBL17104333 | 0.88 | EPHX1 (0.50) | — | |
| SCHEMBL2042220 | 0.88 | EPHX1 (0.50) | — | |
| SCHEMBL1508314 | 0.88 | EPHX1 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 370 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110669058-A | Tricyclic quinolone carboxylic acid and preparation method thereof | 江西农业大学 | 2020-01-10 | — | — | CN | claimed |
| CN-105837766-B | A kind of composite magnetic nano-particle Fe3O4/MPS/PAA/NTA-Ni2+And preparation method thereof and its application in histidine-tagged protein matter is isolated and purified | 湖北工业大学 | 2018-06-26 | — | — | CN | claimed |
| US-20240226226-A1 | KAPPA-OPIOID RECEPTOR AGONIST IMPLANTS FOR TREATMENT OF PRURITUS | TITAN PHARMACEUTICALS INC (US) | 2024-07-11 | — | — | US | disclosed |
| WO-2024140700-A1 | BENZOTHIAZOLE COMPOUND, AND SYNTHESIS THEREFOR AND USE THEREOF | 西北农林科技大学 | 2024-07-04 | — | — | WO | disclosed |
| WO-2024135828-A1 | AVERMECTIN DERIVATIVE | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | 2024-06-27 | — | — | WO | disclosed |
| US-12018267-B2 | Plants having increased tolerance to herbicides | BASF SE (DE) | 2024-06-25 | — | — | US | disclosed |
| US-11992012-B2 | Diaminotriazine compounds | BASF SE (DE) | 2024-05-28 | — | — | US | disclosed |
| EP-4370505-A1 | HERBICIDAL PHENYLURACILS | BASF SE (DE) | 2024-05-22 | — | — | EP | disclosed |
| US-11965171-B2 | Plants having increased tolerance to herbicides | BASF SE (DE) | 2024-04-23 | — | — | US | disclosed |
| CN-117897378-A | Plants with increased tolerance to herbicides | 巴斯夫农业种子解决方案美国有限责任公司 | 2024-04-16 | — | — | CN | disclosed |
| US-11939587-B2 | Plants having increased tolerance to herbicides | BASF SE (DE) | 2024-03-26 | — | — | US | disclosed |
| EP-1127053-A1 | NOVEL 1-ARYL-4-THIOURACILS | BASF AKTIENGESELLSCHAFT (DE) | 2001-08-29 | — | — | EP | disclosed |
| WO-2001048035-A2 | CHEMICAL COMPOUND, METHOD FOR THE PRODUCTION THEREOF AND ITS USE IN CATALYST SYSTEMS FOR PRODUCING POLYOLEFINS | BASELL POLYOLEFINE GMBH (DE) | 2001-07-05 | — | — | WO | disclosed |
| WO-2001025216-A1 | 1-ARYL-1,3-DIHYDRO-IMIDAZOL-2-(THI)ONE DERIVATIVES, PRODUCTION OF SAID COMPOUND AND USE AS A DESSICATING/DEFOLIATING AGENT FOR PLANTS | BASF AKTIENGESELLSCHAFT (DE) | 2001-04-12 | — | — | WO | disclosed |
| EP-1042355-A1 | 11BETA-HALOGEN-7ALPHA-SUBSTITUTED ESTRATRIENES, METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11BETA-HALOGEN-7ALPHA-SUBSTITUTED ESTRATRIENES AND USE OF THE SAME FOR PRODUCING MEDICAMENTS | Schering Aktiengesellschaft (DE) | 2000-10-11 | — | — | EP | disclosed |
| WO-2000026194-A1 | NOVEL 1-ARYL-4-THIOURACILS | BASF AKTIENGESELLSCHAFT (DE) | 2000-05-11 | — | — | WO | disclosed |
| US-6001866-A | ADMINISTERING A COMPOUND WHICH IS AN INHIBITOR OF THE ENZYME 15-LIPOXYGENASE (15-LO). | WARNER-LAMBERT COMPANY (US) | 1999-12-14 | — | — | US | disclosed |
| US-5972980-A | ADMINISTERING AN LIPOXYGENASE INHIBITOR | WARNER-LAMBERT COMPANY (US) | 1999-10-26 | — | — | US | disclosed |
| WO-1999033855-A1 | 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES AND USE OF THE SAME FOR PRODUCING MEDICAMENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-07-08 | — | — | WO | disclosed |
| WO-1997012613-A1 | METHOD FOR TREATING AND PREVENTING INFLAMMATION AND ATHEROSCLEROSIS | WARNER-LAMBERT COMPANY (US) | 1997-04-10 | — | — | WO | disclosed |